Analyst stock forecast
Gilead Sciences Forecast: $159.85 Analyst Target
Direct answer
Gilead Sciences's average price target is $159.85.
The target implies +1.6% from the recorded current price, and the consensus rating is Buy.
The low target implies -19.9%, the high target implies +14.4%, and the range spans 34.3% of the current price.
Forecast evidence checked October 16, 2026.
Get free Gilead Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $157.37
- Average price target
- $159.85
- High price target
- $180.00
- Low price target
- $126.00
- Low target gap
- -19.9%
- Target upside
- +1.6%
- High target gap
- +14.4%
- Target range width
- 34.3%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- October 16, 2026
- Valid through
- October 23, 2026
Explore related company data
Read the frequently asked questions.
What is Gilead Sciences's average price target?
Gilead Sciences's verified average price target is $159.85. The target range is $126.00 to $180.00.
How far are Gilead Sciences's low and high targets from the recorded price?
The low target implies -19.9%, while the high target implies +14.4%.
How many analysts are included in Gilead Sciences's consensus?
The verified consensus includes 26 analysts.
How is Gilead Sciences's target upside or downside calculated?
The average target of $159.85 is divided by the recorded price of $157.37, then one is subtracted to produce +1.6%. This does not guarantee a future return.
When was Gilead Sciences's analyst forecast verified?
The data was verified on 2026-10-16. The dataset is valid through 2026-10-23.